Join the Oncology Voice Network. Join for Free
Difficult KOLs: How to overcome challenges, find success and gain access
Medical Science Liaisons Key Opinion Leaders pre-call planning KOL relationship building overcoming challenges

Difficult KOLs: How to overcome challenges, find success and gain access


Share This Article


Summary

In this episode, Andrea Johnson joins Tom Caravela to delve into effective strategies for Medical Science Liaisons. They explore the value of Key Opinion Leaders (KOLs), emphasizing the importance of pre-call planning and preparation. Andrea shares techniques for building strong connections with KOLs and utilizing internal resources effectively. The conversation covers networking tips, the significance of text relationships, and handling challenging interactions. They discuss overcoming negative experiences and the importance of respect in professional relationships. The episode concludes with key takeaways and a call to action for listeners.

My guest today, is Andrea Johnson, National Director, MSLs. Andrea discusses how to overcome challenges, find success and gain access to difficult KOLs

Andrea shares…

πŸ‘‰ Interesting stories about difficult KOLs
πŸ‘‰ Some effective strategies and best practices for turning around difficult KOLs
πŸ‘‰ Practical tips for KOL relationship building
πŸ‘‰ How important pre-call planning is as a practice
πŸ‘‰ What ideas or creative strategies she has seen work for gaining access with tough KOLs

Click for Source
Medical Science Liaisons, Key Opinion Leaders, pre-call planning, KOL relationship building, overcoming challenges

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies β€” and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies β€” and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN